Tempus Raises $200M in Series F
Tempus has successfully raised $200M in a Series F at a $8.1B valuation led by Baillie Gifford, Franklin Templeton.
Company Overview
Tempus is a HealthTech company headquartered in Chicago, IL, founded in 2015 with 1000+ employees.
AI-powered precision medicine platform
Fundraising Details
- Amount Raised: $200M
- Round Type: Series F
- Valuation: $8.1B
- Date: 2020-09-14
- Investors: Baillie Gifford, Franklin Templeton
About Tempus
AI-powered precision medicine platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Chicago, IL
- Founded: 2015
- Team Size: 1000+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Tempus's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Tempus's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $8.1B valuation marks an important milestone for Tempus, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Tempus is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2020-09-14. For more information about Tempus, visit their headquarters at Chicago, IL.
